E-Mail Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage side effects and improve quality of life, finds a study published by The BMJ today. The researchers say remote monitoring can provide a safe, secure, and "real time" system that optimises symptom management and supports patients to remain at home - and is particularly relevant in the context of the covid-19 pandemic. Effective symptom monitoring and management is essential during chemotherapy for cancer, but current approaches rely on patients recognising that symptoms are severe enough to warrant reporting to their care team. Previous research on remote monitoring during chemotherapy has shown benefits, but is largely based on short trials from a single site or country, making it difficult to draw wider conclusions.